Journal article · 2024 · Open access

Cascade Carrier‐Free Nanoparticles Forming In Situ Nanovaccines for Synergistic Photothermal‐Immunotherapy of Cancer

Chenlu Huang, Hanyong Wang, Xinyu Yang, Qingyu Yu, Hai Wang, Linhua Zhang, Yanli Zhao, Dunwan Zhu

Advanced Functional Materials, 34(29), 2401489 · Published 5 April 2024 · DOI 10.1002/adfm.202401489

Open PDFView at the publisherCite this paper

In brief

“Cascade Carrier‐Free Nanoparticles Forming In Situ Nanovaccines for Synergistic Photothermal‐Immunotherapy of Cancer” is a 2024 journal article by Chenlu Huang and 7 co-authors, published in Advanced Functional Materials. OpenAlex counts 35 citations as of 21 November 2026, which puts it in the top 2% of works published in 2024 by citations. It is open access: the full text is free to read at Advanced Functional Materials.

Citations
35
Most cited in
2025 (14)
Field-weighted impact
2.92
References
57
Authors
8

Abstract

Rapid advances in nanotechnology have made it possible to combine photothermal therapy (PTT) with immunotherapy, enabling to activate an in situ vaccine effect. However, this effect is severely impeded by low antigen presentation level and highly suppressive tumor immune microenvironment (immune “cold” tumors). To overcome the obstacles, multifunctional carrier‐free nanoparticles (FCDP‐NPs) assembled from Fe2+, toll‐like receptor 9 agonist (CpG), cationic lipid (DOTAP) and photothermal agent polydopamine are developed. After intratumoral injection, FCDP‐NPs carrying positive charge are exposed under laser irradiation, which can capture tumor‐associated antigens (TAAs) generated upon post‐PTT to form the nanovaccines (FCD‐NPs@TAAs). The nanovaccines further promote cross‐presentation of TAAs, stimulate adaptive immune responses, and shape immune “hot” tumors. As a result, in situ nanovaccines highly improve survival rates and elicit a durable immune memory that remarkedly prevents tumor metastasis, illustrating a useful platform for PTT synergized with immunotherapy.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Huang, C., Wang, H., Yang, X., Yu, Q., Wang, H., Zhang, L., Zhao, Y., & Zhu, D. (2024). Cascade Carrier‐Free Nanoparticles Forming In Situ Nanovaccines for Synergistic Photothermal‐Immunotherapy of Cancer. Advanced Functional Materials, 34(29), 2401489. https://doi.org/10.1002/adfm.202401489

MLA 9

Huang, Chenlu, et al. “Cascade Carrier‐Free Nanoparticles Forming In Situ Nanovaccines for Synergistic Photothermal‐Immunotherapy of Cancer.” Advanced Functional Materials, vol. 34, no. 29, 2024, p. 2401489. https://doi.org/10.1002/adfm.202401489.

Chicago

Huang, Chenlu, Hanyong Wang, Xinyu Yang, Qingyu Yu, Hai Wang, Linhua Zhang, Yanli Zhao, and Dunwan Zhu. 2024. “Cascade Carrier‐Free Nanoparticles Forming In Situ Nanovaccines for Synergistic Photothermal‐Immunotherapy of Cancer.” Advanced Functional Materials 34 (29): 2401489. https://doi.org/10.1002/adfm.202401489.

Harvard

Huang, C. et al. (2024) ‘Cascade Carrier‐Free Nanoparticles Forming In Situ Nanovaccines for Synergistic Photothermal‐Immunotherapy of Cancer’, Advanced Functional Materials, 34(29), p. 2401489. doi:10.1002/adfm.202401489.

IEEE

C. Huang et al., “Cascade Carrier‐Free Nanoparticles Forming In Situ Nanovaccines for Synergistic Photothermal‐Immunotherapy of Cancer,” Advanced Functional Materials, vol. 34, no. 29, p. 2401489, 2024, doi: 10.1002/adfm.202401489.

BibTeX

@article{huang2024cascade,
  title     = {{Cascade Carrier‐Free Nanoparticles Forming In Situ Nanovaccines for Synergistic Photothermal‐Immunotherapy of Cancer}},
  author    = {Huang, Chenlu and Wang, Hanyong and Yang, Xinyu and Yu, Qingyu and Wang, Hai and Zhang, Linhua and Zhao, Yanli and Zhu, Dunwan},
  journal   = {Advanced Functional Materials},
  year      = {2024},
  volume    = {34},
  number    = {29},
  pages     = {2401489},
  doi       = {10.1002/adfm.202401489},
  url       = {https://doi.org/10.1002/adfm.202401489}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20241111
20251414
20261010

Its field-weighted citation impact is 2.92: it has been cited 2.92 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics

  • photothermal therapy
  • cancer immunotherapy
  • carrier-free nanoparticles
  • CpG
  • DOTAP
  • polydopamine
  • tumor-associated antigens
  • cross-presentation

Work with this paper

Most-cited papers in Engineering

All highly cited Engineering papers

Questions about this paper

How do I cite this paper in APA style?

Huang, C., Wang, H., Yang, X., Yu, Q., Wang, H., Zhang, L., Zhao, Y., & Zhu, D. (2024). Cascade Carrier‐Free Nanoparticles Forming In Situ Nanovaccines for Synergistic Photothermal‐Immunotherapy of Cancer. Advanced Functional Materials, 34(29), 2401489. https://doi.org/10.1002/adfm.202401489

How many times has this paper been cited?

35 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Advanced Functional Materials: sign in and open the PDF from this page.

Who wrote this paper?

Chenlu Huang, Hanyong Wang, Xinyu Yang, Qingyu Yu, Hai Wang, Linhua Zhang, Yanli Zhao, Dunwan Zhu.

What is the DOI of this paper?

10.1002/adfm.202401489, permanently at https://doi.org/10.1002/adfm.202401489. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.